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Background: Spinal cord transection and peripheral nerve transection cause muscle atrophy and muscle fiber type
conversion. It is still unknown how spinal cord transection and peripheral nerve transection each affect the
differentiation of muscle fiber type conversion mechanism and muscle atrophy. The aim of our study was to
evaluate the difference of muscle weight change, muscle fiber type conversion, and Peroxisome proliferator-activated
receptor-γ coactivatior-1α (PGC-1α) expression brought about by spinal cord transection and by peripheral
nerve transection.
Methods: Twenty-four Wistar rats underwent surgery, the control rats underwent a laminectomy; the spinal cord injury
group underwent a spinal cord transection; the denervation group underwent a sciatic nerve transection. The rats were
harvested of the soleus muscle and the TA muscle at 0 week, 1 week and 2 weeks after surgery. Histological
examination was assessed using hematoxylin and eosin (H&E) staining and immunofluorescent staing. Western blot
was performed with 3 groups.
Results: Both sciatic nerve transection and spinal cord transection caused muscle atrophy with the effect being more
severe after sciatic nerve transection. Spinal cord transection caused a reduction in the expression of both sMHC protein
and PGC-1α protein in the soleus muscle. On the other hand, sciatic nerve transection produced an increase in
expression of sMHC protein and PGC-1α protein in the soleus muscle. The results of the expression of PGC-1α were
expected in other words muscle atrophy after sciatic nerve transection is less than after spinal cord transection,
however muscle atrophy after sciatic nerve transection was more severe than after spinal cord transection.
Conclusion: In the conclusion, spinal cord transection diminished the expression of sMHC protein and PGC-1α protein
in the soleus muscle. On the other hand, sciatic nerve transection enhanced the expression of sMHC protein and PGC-1α
protein in the soleus muscle.
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Nerve injury produces significant physiological and bio-
chemical changes in skeletal muscle. These changes in-
clude loss of muscle mass, alteration in muscle fiber
type, reduction in mitochondrial concentration, increase
in resting blood flow, alteration in metabolite levels, and
decrease resistance to fatigue [1-9].
Skeletal muscle contains two different types of muscle
fiber: slow muscle fibers and fast muscle fibers [10,11]. It* Correspondence: kosahigasino@gmail.com
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reproduction in any medium, provided the orhas been reported that spinal cord transection and dener-
vation of peripheral nerve converts muscle fiber type from
slow to fast phenotype in the soleus muscle [2,3,8,9,12-14].
The underlying mechanism of muscle fiber type conver-
sion has not been well documented. However, recently
it has been reported PGC-1α (peroxisome proliferator-
activated receptor-γ coactivatior-1α) plays an important
role in the conversion of fast muscle fiber into slow muscle
fiber during skeletal muscle repair [15,16]. Peroxisome
proliferator-activated receptor-γ coactivatior-1α (PGC-1α)
is expressed in several tissues, including skeletal muscleral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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muscle fibers [17,18]. PGC-1α is expressed in skeletal
muscle, and induces mitochondrial biogenesis as well as
activity of the myoglobin [15,16].
It is still not known how spinal cord transection and
peripheral nerve transection each affect the differentiation
of muscle fiber type conversion mechanism, muscle atro-
phy and PGC-1α expression. These findings led us to
hypothesize that the degree of muscle atrophy is different
between spinal cord injury and peripheral nerve injury,
and PGC-1α expression is correlated to fiber type conver-
sion after either of these injuries. The aim of this study
was to evaluate the difference of muscle atrophy and fiber
type conversion between after spinal cord injury and after
peripheral nerve injury. Furthermore, we investigated the
relationship between the muscle fiber type conversion and
the PGC-1α expression in both injuries.
Materials and methods
Animal and experimental protocol
This study protocol conformed with the guidelines for
the care and approved by a scientific board as well as
the animal ethics committee of our University. After
this approval twenty-four 8-week-old female Wistar rats,
weighing 190.6 ± 3.9 g, were obtained from Charles River
Japan Co., Ltd. (Yokohama, Japan). The rats were housed
in individual cages and kept in a temperature and humidity
controlled room (temperature 23 +/− 2C; humidity 55 +/−
10%) on a cycle consisting of 12 hours light and 12 hours
dark. The rats had free access to food and water. The 24 rats
were divided into three groups (n = 8): 1) the control rats
underwent a laminectomy at T7-T8; 2) the rats in the
spinal cord injury group underwent a laminectomy at T7-
T8 followed by a spinal cord transection with a gap of
5 mm; 3) the rats in the denervation group underwent a
sciatic nerve transection by removal of a sciatic nerve sec-
tion 10 mm in length at both thighs.
The rats in the control group were euthanized at 0 week
(n = 4), 1 week (n = 2) and 2 weeks (n = 2) after surgery.
The rats in the spinal cord transection group were
euthanized at 1 week (n = 4) and 2 weeks (n = 4) after sur-
gery. The rats in the sciatic nerve transection group were
euthanized at 1 week (n = 4) and 2 weeks (n = 4) after sur-
gery. Each time a rat was euthanized its body weight was
measured and then the soleus and tibialis anterior muscles
were both harvested bilaterally. The muscle weight to
body weight ratio was calculated. The soleus and tibialis
anterior muscles were flash-frozen in 2-methylbutane pre-
cooled in liquid nitrogen, and stored at −80 C pending
histological analysis and Western blot analysis.
Histological examination
Consecutive soleus and tibialis anterior muscle sections
were cut in 5-μm-thick sections using the cryostat (LeicaMicrosystems AG, Wetzlar, Germany). Histological exam-
ination of muscle fiber atrophy was assessed using hema-
toxylin and eosin (H&E) staining. The diameters of the
muscle fibers were measured using computerized inter-
active software (Win ROOF, Mitani Co. Fukui & Tokyo,
Japan); at least 100 fibers per specimen were counted
(magnification × 200) (Mitani Co. Fukui & Tokyo, Japan).
For immunofluorescent staining 5-μm thick sections
were cut and washed 3 times in PBS. The sections were
fixed with 4% paraformaldehyde for 5 minutes. They were
again washed 2 times and then blocked with normal horse
serum for 1 hour. The sections were incubated with
monoclonal anti-slow myosin heavy chain (sMHC) anti-
body (dilution 1:200; Sigma, St. Louis, MO) for 1 hour.
After being washed 3 times, the sections were incubated
with anti-mouse IgG-Cy3 conjugate antibody (dilution
1:250; Sigma, St. Louis, MO). After being washed 3 times
the sections were viewed under the fluorescent micro-
scope to visualize the immunofluorescent results (Nikon,
E600 and TE2000U, Tokyo, Japan). For the measurement
of the muscle fiber type conversion, the sMHC muscle
fibers (stained red) were measured on the cross-sectional
area using computerized interactive software (Win ROOF,
Mitani Co. Fukui & Tokyo, Japan).
Western blot analysis
Muscle samples were homogenized and lysed with RIPA
buffer (Tris–HCl, NaCl, 1% TritonX-100, EDTA · 2Na ·
H20). The protein concentration on each sample was de-
termined using the Lowry method [19]. Western blot
was performed with total tissue homogenates on 7% and
10% polyacrylmamide gels after the protein content was
quantified. A total of 30 μg protein was applied on each
lane of the gels. The following antibodies were used; anti-
PGC-1 (dilution 1:1000; AB3242, Chemicon, Temecula,
CA), NOQ7.5.4D, monoclonal mouse anti-slow myosin
heavy chain (sMHC) antibody (1:1000; Sigma, St. Louis,
MO). Anti-β-actin (diluted 1:1000; Sigma) was used for
protein quantification.
The statistical difference was determined by Mann-
Whitney’s U test. All statistical analyses were performed
using StatView, version 5.0 (Abacus Concepts, Berkeley,
CA), with P < 0.05 considered statistically significant.
Results
Two weeks after surgery, the body weights of the rats that
had received spinal cord transection were significantly less
than the body weights of the rats that had received sciatic
nerve transection. Spinal cord transection and sciatic nerve
transection caused severe muscle weight loss for both the
soleus and the tibialis anterior muscles. The muscle weight
and the muscle weight to body weight ratio after sciatic
nerve transection were both significantly less than those
after spinal cord transection (Table 1, Figure 1).
Table 1 Initial and final body weight and muscle weight
0w Control 2w SCT 2w SNT 2w
Body weight (g), 190.6 ± 3.9 222.5 ± 4.6† 209.1 ± 2.6 †‡ 222.1 ± 5.2 ‡
TA (mg) 35.1 ± 2.8 43.1 ± 3.2† 30.0 ± 5.6 †‡ 21.4 ± 2.4 ‡
TA/body weight (mg/g) 18.4 19.4† 14.8 †‡ 9.6 ‡
Soleus (mg) 108.8 ± 5.6 123.2 ± 9.3† 77.3 ± 2.7 †‡ 44.6 ± 4.6 ‡
Soleus/body weight (mg/g) 0.57 0.55† 0.037 †‡ 0.020 ‡
†‡ Mann–Whitney U test, alpha = 0.05, †‡ Significant difference.
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muscle fiber was 96.3 ± 22.5 μm at 0 week, 96.0 ± 16.8 μm
at 1 week, and 96.3 ± 13.6 μm at 2 weeks. In the spinal
cord transection group, the mean diameter of the soleus
muscle fiber was 69.1 ± 16.8 μm at 1 week after surgery,
and 67.4 ± 13.6 μm at 2 weeks after surgery. In the sciatic
nerve transection group, the mean diameter on the soleus
muscle fiber was 61.4 ± 17.9 μm at 1 week after surgery
and 39.4 ± 13.5 μm at 2 weeks after surgery. The mean
diameter of the soleus muscle fiber was significantly less
in the sciatic nerve transection group than in the spinal
cord transection group at both time points (Figure 2).
In the control group, the mean diameter of the tibialis
anterior muscle fiber was 76.9 ± 15.4 μm at 0 week, 78.9 ±
15.7 μm at 1 week, and 78.5 ± 12.5 μm at 2 weeks. In the
spinal cord transection group the mean diameter of the
tibalis anterior muscle fiber was 62.2 ± 15.8 μm at 1 week
after surgery, and 54.0 ± 12.6 μm at 2 weeks after surgery.
In the sciatic nerve transection group the mean diameter
of the tibialis anterior muscle fiber was 57.7 ± 13.7 μm at
1 week, after surgery and 50.5 ± 12.1 μm at 2 weeks after
surgery. There were no significant differences at either
time point in the mean diameter of tibialis anterior muscle
fibers between the sciatic nerve transection group and the
spinal cord transection group (Figure 3).
In the control group at 0 week for the soleus muscle the
percentage of the area stained sMHC antibody showedFigure 1 Two weeks after surgery, macroscopic anatomy of both tibi
of the muscle in the sciatic nerve transection group was severe than98.8% ± 0.2% in the cross-sectional area. In the spinal cord
transection group, for the soleus muscle the percentage of
the area stained sMHC antibody was 75.6% ± 6.2% at
1 week after surgery and 73.6% ± 3.8% at 2 weeks after
surgery. In the sciatic nerve transection group, for the
soleus muscle the percentage of the area stained sMHC
antibody was 86.0% ± 5.4% at 1 week after surgery and
86.0% ± 5.7% at 2 weeks after surgery. The percentage of
the area stained sMHC antibody was significantly greater
in the sciatic nerve transection group than in the spinal
cord transection group at both time points (Figure 4).
In the control group at 0 week, for the tibialis anterior
muscle superficial area no part of the cross sectional area
stained sMHC antibody. In the spinal cord transection
group, for the tibialis anterior muscle superficial area the
percentage of the area that stained sMHC antibody was
1.3% ± 0.1% at 1 week after surgery and 1.5% ± 0.4% at
2 weeks after surgery. In the sciatic nerve transection
group, for the tibialis anterior muscle superficial area the
percentage of the area that stained sMHC antibody was
2.3% ± 0.7% at 1 week after surgery and 3.1% ± 0.3% at
2 weeks after surgery. The percentage of the area stained
sMHC antibody was significantly greater in the sciatic
nerve transection group than in the spinal cord transec-
tion group at both time points (Figure 5).
In the sciatic nerve transection group, the expression
of sMHC protein in the soleus muscle was greater thanalis anterior muscle (TA) and soleus muscle showed the atrophy
that in spinal cord transection group.
Figure 2 The mean diameter of the soleus muscle fiber in the sciatic nerve transection group was significantly less than that in the
spinal cord tarnsection group. The open bars indicate the control at 0 week, 1 week and 2 weeks, the gray bars indicate 1 week and 2 weeks
after spinal cord transection, and the black bars indicate 1 week and 2 weeks after sciatic nerve transection.
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sion of PGC-1 protein was also greater in relation to the
expression of sMHC protein in the soleus muscle after
sciatic nerve transection. On the other hand, in the
spinal cord transection group, the expression of sMHC
protein in the soleus muscle was less than that in the
control group. The expression of PGC-1 protein wasFigure 3 The mean diameters of the tibalis anterior muscle fiber in th
transection group were less than those in the control group. There w
anterior muscle fiber in the spinal cord transection group and in the sciatic
1 week and 2 weeks, the gray bars indicate 1 and 2 weeks after spinal cord
nerve transection.also decreased in the soleus muscle after spinal cord
transection (Figure 6).
Discussion
The main results to emerge from this experiment are:
1) Both sciatic nerve transection and spinal cord tran-
section caused muscle atrophy with the effect beinge spinal cord transection group and in the sciatic nerve
as no significant difference between the mean diameter of tibialis
nerve transaction group. The open bars indicate control at 0 week,
transection, and the black bars indicate 1 and 2 weeks after sciatic
Figure 4 Immunofluorescent staining for the slow myosin heavy chain (sMHC). The red muscle fibers on the cross-sectional area were
positive for sMHC antibody. For the soleus muscle the percentage of positive area in the spinal cord transection group was significantly less than
that in the sciatic nerve transection group.
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transection reduced the percentage of the area stained
sMHC antibody in the soleus muscle. Sciatic nerve tran-
section did not reduce the percentage of the area stained
sMHC antibody in the soleus muscle strongly. For the
tibialis anterior muscle sciatic nerve transection increased
the percentage of the area stained sMHC antibody greater
than the spinal cord transection. 3) Spinal cord transec-
tion caused a reduction in the expression of both sMHC
protein and PGC-1α protein in the soleus muscle. On theFigure 5 In the control group, the tibialis anterior superficial (TA) mu
(sMHC) antibody. The percentage of the positive area at 1 week and 2 we
than that in the spinal cord transection group.other hand, sciatic nerve transection produced an increase
in expression of sMHC protein and PGC-1α protein in
the soleus muscle.
At 2 weeks after surgery the body weight of the rats in
the sciatic nerve transection group was greater than that
of the rats in the spinal cord transection group. For the so-
leus muscle, the atrophy of the muscle fiber as well as the
muscle weight loss were both greater in the sciatic nerve
transection group as compared to that in spinal cord tran-
section group. Thus, although the body weight of the ratsscle fibers were negative for staining of slow myosin heavy chain
eks in the sciatic nerve transection group was significantly greater
Figure 6 Western blot pattern showed the expression of sMHC (slow myosin heavy chain) in the soleus muscle decreased with time
after spinal cord transection, whereas increased with time after sciatic nerve transection. For the tibialis anterior muscle, there was no
observed expression of the proteins of sMHC and PGC-1 (peroxisome proliferator-activated receptor-γ coactivatior-1α) in the spinal cord
transection group and in the sciatic nerve transection group. β actin, as a control.
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general nutrition, this was not reflected in muscle weight,
which decreased.
For both the soleus muscle and tibialis anterior muscle
the percentage of slow muscle fiber was significantly
greater in the sciatic nerve transection group than in the
spinal cord transection group. These results indicate that
spinal cord transection reduced slow muscle fiber type.
On the other hand, sciatic nerve transection did not re-
duce slow muscle fiber type strongly.
Our results show that the soleus muscle contains 98%
slow type muscle fibers and is strongly affected by sciatic
nerve transection. In the spinal cord transection group,
our immunofluorescent results and Western blotting re-
sults show that sMHC- expressing muscle fibers in the
soleus muscle decreased with time. For the soleus muscle,
the protein level of PGC-1α also showed a decrease with
time in the spinal cord transection group. The expression
of PGC-1α was abundant in skeletal muscle, particularly
in slow fiber types. PGC-1α induces the production of
mitochondria and synthesis of slow contractile proteins
[16]. It was reported that PGC-1α activation plays an im-
portant role in up-regulating the formation of slow muscle
fibers [17,18]. Slow muscle fibers expression and PGC-1α
protects against muscle atrophy due to the inhibition of
atrogenes [18,20].Our results for the tibialis anterior muscle after sciatic
nerve transection show a relationship between the ex-
pression of sMHC and the increase in expression of
PGC-1α. The results of the expression of PGC-1α were
expected in other words muscle atrophy after sciatic
nerve transection is less than after spinal cord transec-
tion, however muscle atrophy after sciatic nerve transec-
tion was more severe than after spinal cord transection.
The difference between spinal cord injury and peri-
pheral injury is survival of the γ-loop pathway [21,22].
Destruction of the γ-loop pathway causes severe muscle
atrophy and induced slow muscle fiber type conversion
in fast muscle fiber muscle [23].
Future studies will need to be carried out to investi-
gate the relationship between skeletal muscle atrophy
and fiber type conversion after spinal cord transection
and sciatic nerve transection.
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